Pleural space as a site of ectopic gene delivery: Transfection of pleural mesothelial cells with systemic distribution of gene product

Chest

Volumn 123, Issue 1, 2003, Pages 202-208

  Devin, Clinton J ^a   Lee, Gary ^b   Light, Richard W ^b   Lane, Kirk B ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b SAINT THOMAS HOSPITAL   (United States)

Author keywords

Gene therapy; Mesothelial cells; Pleura

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; ENZYME ASSAY; ENZYME RELEASE; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; MESOTHELIUM; MESOTHELIUM CELL; NONHUMAN; PILOT STUDY; PLASMID; PLEURA CAVITY; PLEURA FLUID; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPORTER GENE; TUBE;

EID: 0037252323     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.1.202     Document Type: Article

References (22)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986
2. Kaufman RJ. Advances toward gene therapy for hemophilia at the millennium. Hum Gene Ther 1999; 10:2091-2107
3. Bierich JR. Therapy with growth hormone: old and new indications. Horm Res 1989; 32:153-165
4. Stockley RA. Alpha-1-antitrypsin deficiency: what next? Thorax 2000; 55:614-618
5. Flowers ME, Stockschlaeder MA, Schuening FG, et al. Long-term transplantation of canine keratinocytes made resistant to G414 through retrovirus-mediated gene transfer. Proc Natl Acad Sci USA 1990; 87:2349-2353
6. Armentano D, Thompson AR, Darlington G, et al. Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: Potential for gene therapy of hemophilia B. Proc Natl Acad Sci USA 1990; 87:6141-6145
7. Dzierzak E, Papayannopoulou T, Mulligan R. Lineage-specific expression of a human beta-globin gene in murine bone marrow transplant recipients reconstituted with retrovirus-transduced stem cells. Nature 1988; 331:35-41
8. Nagy JA, Shockley TR, Masse EM, et al. Systemic delivery of a recombinant protein by genetically modified mesothelial cells reseeded on the parietal peritoneal surface. Gene Ther 1995; 2:402-410
9. Murphy J-E, Rheinwald JG. Intraperitoneal injection of genetically modified, human mesothelial cells for systemic gene therapy. Hum Gene Ther 1997; 8:1867-1879
10. Setoguchi Y, Jaffe HA, Chu C-S, et al. Intraperitoneal in vivo gene therapy to deliver α-1 antitrypsin to the systemic circulation. Am J Respir Cell Mol Biol 1994; 10:369-377
11. Smythe WR, Kaiser LR, Hwang HC, et al. Successful adenovirus-mediated gene transfer in an in-vivo model of human malignant mesothelioma. Ann Thorac Surg 1994; 57:1395-1401
12. McComb RB, Bowers GN Jr. Study of optimum buffer conditions for measuring alkaline phosphatase activity in human serum. Clin Chem 1972; 18:97-104
13. Light RW, DS Cheng, YC Lee, et al. A single intrapleural injection of transforming growth factor-beta 2 produces an excellent pleurodesis in rabbits. Am J Respir Crit Care Med 2000; 162:98-104
14. Lee YCG, Teixeira LR, Devin CJ, et al. Transforming growth factor-β2 induces pleurodesis significantly faster than talc. Am J Respir Crit Care Med 2001; 163:640-644
15. Sahn SA. The pleura. Am J Respir Crit Care Med 1988; 138:184-234
16. Wang NS. Anatomy of the pleura. Clin Chest Med 1998; 19:229-240
17. Rheinwald JG, Jorgensen JL, Hahn WC, et al. Mesosecrin: a secreted glycoprotein produced in abundance by human mesothelial cells, endothelial, and kidney epithelial cells in culture. J Cell Biol 1987; 104:263-275
18. Cicila GT, O'Connell TM, Hahn WC, et al. Cloned cDNA sequence for the human mesothelial protein mesosecrin discloses its identity as a plasminogen activator inhibitor (PAI-1) and recent evolutionary change in transcript processing. J Cell Sci 1989; 94:1-10
19. Light RW. Pleural diseases. 4th ed. Baltimore, MD: Lippincott Williams & Wilkins, 2001; 8-20
20. Loser P, Jennings GS, Strauss M, et al. Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: Involvement of NFκB. J Virol 1998; 72:180-190
21. Harms JS, Splitter GA. Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoter but augments expression driven by the mammalian MHC I promoter. Hum Gene Ther 1995; 6:1291-1297
22. Crystal RC, McElvaney NG, Rosenfeld MA, et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 1994; 8:42-51